ArticleVeterinary sciences2025
Metabolic Profiles of Feline Obesity Revealed by Untargeted and Targeted Mass Spectrometry-Based Metabolomics Approaches.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum metabolomics identifies metabolic changes in obese cats fed enzymatically hydrolyzed poultry byproduct meal.Journal of veterinary internal medicine · 2026Trial
- Overweight and Obesity in Dogs and Cats: An Exploration of Animal Welfare and Behaviour Impacts, and Recommendations for Management in Veterinary Primary Care.Animals : an open access journal from MDPI · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Obesity is currently one of the major medical problems affecting humans and companion animals, including cats; however, a detailed understanding of the metabolic processes altered in feline obesity remains limited. This study aimed to investigate obesity-related changes in the serum metabolome of three groups of cats, metabolically healthy normal-weight (MHN) cats, metabolically healthy overweight (MHO) cats, and metabolically unhealthy overweight (MUO) cats. Metabolome changes were assessed using LC-MS (untargeted), LC-MS (targeted), and FIA-MS (targeted) methods. Untargeted analysis detected 141 significant annotated features, while targeted approach identified 48 metabolites significantly associated with obesity. Both untargeted and targeted analyses showed lower kynurenine levels in the MUO group compared to the MHN group. Targeted LC-MS analysis identified 11 significant metabolites, whereas the FIA-MS approach detected 37. Four metabolites-glycine, citrulline, and two phosphatidylcholines-were found at lower levels in the MHO group compared to the MHN group. Arginine and proline metabolism, along with methionine metabolism, were significantly altered pathways, while thyroid hormone synthesis was independently altered with the highest enrichment ratio. The obtained results suggest that cats with a healthy phenotype exhibit an intermediate-metabolic-risk profile and provide new insights into the metabolic mechanisms and pathways underlying feline obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.